HYPD
Hyperion Defi Inc
NASDAQ · Pharmaceuticals
$4.14
+0.68 (+19.65%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 5.38M | 5.01M | 5.20M |
| Net Income | 1.66M | 1.46M | 1.25M |
| EPS | — | — | — |
| Profit Margin | 30.8% | 29.2% | 24.0% |
| Rev Growth | +23.3% | +22.0% | +7.9% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 11.00M | 11.29M | 13.39M |
| Total Equity | 26.37M | 25.06M | 25.22M |
| D/E Ratio | 0.42 | 0.45 | 0.53 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 2.19M | 1.99M | 2.29M |
| Free Cash Flow | 1.17M | 1.60M | 1.59M |